Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Invest New Drugs. 2015 May 8;33(4):963–968. doi: 10.1007/s10637-015-0246-2

Table 1.

Patient baseline demographics.

Total (N=20)

Age
 Median 61.5
 Range (51.0-81.0)
Gender
 Female 9 (45.0%)
 Male 11 (55.0%)
Ascites Present
 Yes 2 (10.0%)
 No 18 (90.0%)
Performance Score
 0 10 (50.0%)
 1 9 (45.0%)
 2 1 (5.0%)
Race
 White 19 (95.0%)
 Black or African American 1 (5.0%)
Prior Surgery
 Yes 8 (40.0%)
 No 12 (60.0%)
Previous Radiation Therapy
 Yes 2 (10.0%)
 No 18 (90.0%)
Prior Therapy
 Yes 2 (10.0%)
 No 18 (90.0%)